Ono Pharmaceutical Co., Ltd.

4528

JP3197600004

Pharmaceuticals

Delayed Japan Exchange Other stock markets 10:19:19 2024-05-09 pm EDT			5-day change	1st Jan Change
2,266 ^JPY	-0.35%		-1.71%	-9.94%

Apr. 30	Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	RE
Apr. 29	US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week	MT

Ono Pharmaceutical Co., Ltd. Provides Earnings Forecast for the Year 2021

July 30, 2021 at 01:00 am EDT

Ono Pharmaceutical Co., Ltd. provided earnings forecast for the year 2021. For the period, The company expects sales of JPY 110 billion.

Latest news about Ono Pharmaceutical Co., Ltd.

Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	Apr. 30	RE
US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week	Apr. 29	MT
Sector Update: Health Care Stocks Edge Higher Late Afternoon	Apr. 29	MT
Top Midday Gainers	Apr. 29	MT
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading	Apr. 29	MT
Sector Update: Health Care	Apr. 29	MT
Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical	Apr. 29	MT
Deciphera Shares Hit 2-Year High After $2.4 Billion Buyout Offer From ONO Pharma	Apr. 29	DJ
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	Apr. 29	MT
Sector Update: Health Care	Apr. 29	MT
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	Apr. 29	MT
Deciphera Pharmaceuticals Gets $2.4 Billion Buyout Offer From ONO Pharmaceutical	Apr. 29	DJ
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	Apr. 29	MT
Japan's Ono Pharmaceutical to buy Deciphera for $2.4 billion	Apr. 29	RE
Ono Pharmaceutical Co., Ltd. entered into a definitive merger agreement to acquire Deciphera Pharmaceuticals, Inc. for $2.2 billion.	Apr. 28	CI
ONO Pharmaceuticals, Co., Ltd. Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL	Mar. 21	CI
Sibylla Biotech Enters Strategic Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. in Central Nervous System Disorders	Mar. 14	CI
Ono Pharmaceutical Co., Ltd. Enters into A University-Wide, Research Alliance Agreement with Harvard University	Mar. 11	CI
Jefferies Adjusts Ono Pharmaceutical’s Price Target to 2,400 Yen From 2,300 Yen, Keeps at Hold	Mar. 11	MT
Tranche Update on Ono Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023.	Mar. 04	CI
Ono Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 25, 2023, has closed with 18,732,400 shares, representing 3.88% for ¥49,999.75 million.	Feb. 29	CI
Transcript : Ono Pharmaceutical Co., Ltd. - Special Call	Feb. 21
InveniAI LLC Announces Collaboration with Ono Pharmaceutical for Target Discovery	Feb. 19	CI
Shattuck Labs Collaborates With Ono Pharmaceutical to Develop Fusion Proteins	Feb. 14	MT
Shattuck Strikes Joint Development Deal With Japan's Ono Pharma	Feb. 13	DJ

Chart Ono Pharmaceutical Co., Ltd.

Duration

Period

More charts

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.

Sector

Pharmaceuticals

Calendar

2024-07-28 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Ono Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2,274 JPY

Average target price

2,698 JPY

Spread / Average Target

+18.65%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ONO PHARMACEUTICAL CO., LTD.	-9.94%	6.92B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+18.67%	43.74B
OTSUKA HOLDINGS CO., LTD.	+23.56%	22.26B
SANDOZ GROUP AG	+16.41%	14.9B
CIPLA LIMITED	+9.03%	13.39B
ZYDUS LIFESCIENCES LIMITED	+40.48%	12.12B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.13%	5.47B
RICHTER GEDEON VEGYÉSZETI GYÁR NYILVÁNOSAN MUKÖDO RT.	+9.14%	4.83B

Generic Pharmaceuticals